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Background
With the introduction of HAART in many HIV treat-
ment centers in Nigeria, there has been a decreased
incidence of AIDS-related mortality and growing con-
cern about the incidence of AIDS specific and non-
AIDS specific cancers. This study thus sought to investi-
gate patterns and incidence of cervical and anal warts
among patients in a Special Treatment Center (SPC)
before being diagnosed of having HIV and after starting
ARVs.
Material and methods
We linked results from a population-based HIV registry
in our SPC with that of two cancer registries and evalu-
ated the risk of developing anal or cervical warts a year
prior to onset of ARV and a year after commencement
of HAART. Standardized incidence ratios (SIRs) were
calculated to relate presence of cervical and anal warts
in people with AIDS to that in the general population.
We also used logistic regression with 95% confidential
interval to compare risk according to demographic fac-
tors and CD4 count.
Results
The study involved 542 patients diagnosed with HIV
within the two years of the study. Persons with AIDS
had elevated risks of cervical warts (SIR=11.7, 95% CI
6.2-14.4, n=52) and anal warts (SIR=1.8, 95% CI 1.3-2.7,
n=13). Risk for cervical warts increased with increasing
time relative to AIDS onset (p=0.02), this trend was not
significant for anal warts (p=0.12). Risk of developing
both warts was unrelated to CD4 count at onset of
treatment (p=0.43).
Conclusions
There is a modest excess risk of developing cervical and
anal warts among this group of patients. The risk seems
to increase with increasing years on ARVs. This is not
related to the immune state of the patients. There is a
need to pay attention to patients on ARV therapy as
they advance in years with ARV medication.
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